SCHEMBL6537425

SCHEMBL6537425

O=C(Nc1cccc2cc(-c3ccccc3)cnc12)c1c(Cl)cccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.51
PARP1 P09874 1/20 0.51
KDM4E B2RXH2 1/20 0.50
MAPT P10636 5/20 0.48
PLEC Q15149 1/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
EGLN3 Q9H6Z9 1/20 0.46
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 1/20 0.46
TSHR P16473 1/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537841 0.89 KDR (0.45) KDRPARP1MAPTPLECMEN1
Hydrochloric Acid SCHEMBL6538227 0.85 KDR (0.52) KDRMAPTPLECMEN1KMT2A
SCHEMBL6538256 0.84 MAPT (0.52) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537382 0.82 SLC40A1 (0.52) KDRPARP1KDM4EMAPTPLEC
SCHEMBL6537536 0.82 KDR (0.52) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537913 0.81 KDR (0.47) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537481 0.81 MAPT (0.46) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537743 0.81 KDR (0.48) KDRKDM4EMAPTPLECMEN1
SCHEMBL6537852 0.81 KDR (0.48) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537399 0.81 KDR (0.49) KDRMAPTPLECMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed